Glycobiology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Glycobiology Market is segmented by Product, Application, End-User and Geography

Glycobiology Market Snapshot

Glycobiology Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Europe
Largest Market: North America
CAGR: 14.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The glycobiology market will show rapid growth due to the increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies.

  • The major pharmaceutical and biotech companies are heavily investing in the research and development of superior biological products, such as glycobiology products and products related to proteomics.  
  • There is also an increased demand for curative treatments for many life-threatening diseases, such as cancer, which is expected to drive the pace of pharmaceutical and biotechnological R&D, as well as overall investments made in glycobiology field. This makes glycobiology an attractive option for big pharma and biotech companies to invest in. Furthermore, glycomic biomarkers have significant applications in drug development and diagnostics for many diseases.
  • In addition, a huge amount of investment is put into the development of its products and the approval of drugs that are developed, require a lot of regulatory stages that are necessary for the process. This, in turn, renders these products very expensive.

Scope of the Report

As per the scope of the report, glycobiology is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets.

By Product
Enzymes
Instruments
Kits
Reagents
By Application
Diagnostics
Drug Discovery and Development
Oncology
Immunology
Other Applications
By End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Drug Discovery and Development is Expected to be the Largest Growing Segment

On the basis of application, drug discovery and development has been accounted for the largest market share. This is primarily owing to extensive R&D and increased government funding for research related to glycomics and proteomics. There is an increasing R&D investments by pharmaceutical companies, which increases the drug discovery and development of glycomics. For instance, R&D expenditure of Merck accounted for USD 9.8 billion, in 2018.

The other applications segment is anticipated to witness the high CAGR due to rising clinical trials and R&D expenses incurred by key companies for research.

Glycobiology Market

North America is Found Leading the Glycobiology Market

North America has been accounted for the largest market share due to the presence of key pharmaceutical and biopharmaceutical companies. The presence of well-established healthcare infrastructure and accessibility to advanced products have driven the regional market. Moreover, there is also increasing applications of glycans in various cancers and increasing funds from the government in enhancing the field of glycobioogy, that helps the market to grow over the forecast period.

 

Glycobiology Market

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to the market growth. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Government and Private Funding for Glycomics and Proteomics Research

      2. 4.2.2 Growing R&D Expenditure by Pharmaceutical and Biotechnology Companies

    3. 4.3 Market Restraints

      1. 4.3.1 High Product Cost

      2. 4.3.2 Low Availability of Skilled Professionals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Enzymes

      2. 5.1.2 Instruments

      3. 5.1.3 Kits

      4. 5.1.4 Reagents

    2. 5.2 By Application

      1. 5.2.1 Diagnostics

      2. 5.2.2 Drug Discovery and Development

      3. 5.2.3 Oncology

      4. 5.2.4 Immunology

      5. 5.2.5 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Contract Research Organizations

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies

      2. 6.1.2 Bruker Corporation

      3. 6.1.3 Danaher Corporation

      4. 6.1.4 Merck KGaA

      5. 6.1.5 New England Biolabs

      6. 6.1.6 ProZyme

      7. 6.1.7 Shimadzu Corporation

      8. 6.1.8 Takara Bio

      9. 6.1.9 Thermo Fisher Scientific

      10. 6.1.10 Waters Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Glycobiology Market market is studied from 2018 - 2026.

The Glycobiology Market is growing at a CAGR of 14.6% over the next 5 years.

Europe is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Agilent Technologies, Waters Corporation, Shimadzu Corporation, Merck KGaA, New England Biolabs are the major companies operating in Glycobiology Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!